M

Marrone Bio Innovations Inc
F:0MB

Watchlist Manager
Marrone Bio Innovations Inc
F:0MB
Watchlist
Price: 0.965 EUR -3.02%
Market Cap: 176m EUR

Net Margin
Marrone Bio Innovations Inc

-47.1%
Current
-75%
Average
4.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-47.1%
=
Net Income
-20.9m
/
Revenue
44.4m

Net Margin Across Competitors

Marrone Bio Innovations Inc
Glance View

Market Cap
175.9m EUR
Industry
Chemicals

Marrone Bio Innovations, Inc. engages in the provision of biological-based solutions for agricultural crops, turf protection, seed treatment, plant health and waterway systems. The company is headquartered in Raleigh, North Carolina and currently employs 153 full-time employees. The company went IPO on 2013-08-02. The Company’s products include Emergen, Foramin, Foramin ST, Grandevo, Haven, Jet-Ag, Jet-Oxide, Majestene, Pacesetter, Regalia, Stargus, UBP, UBP ST, Venerate and Zelto. Its product categories include products, which are referred to as biopesticides, bioinsecticides, bionematicides, biofungicides, biostimulants and bionutrition. Its pipeline consists of products in three categories: bioprotection, seed and soil health, and plant health. The Company’s markets include row crops, such as corn and soybeans; fruits and vegetables, such as tomatoes, leafy greens and cucurbits, trees; nuts and vines, such as almonds and grapes, and greenhouse production, such as ornamentals and medicinal plants.

0MB Intrinsic Value
Not Available
M
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-47.1%
=
Net Income
-20.9m
/
Revenue
44.4m
What is the Net Margin of Marrone Bio Innovations Inc?

Based on Marrone Bio Innovations Inc's most recent financial statements, the company has Net Margin of -47.1%.

Back to Top